ASENDIN Drug Patent Profile

✉ Email this page to a colleague

When do Asendin patents expire, and what generic alternatives are available?

Asendin is a drug marketed by Lederle and is included in one NDA.

The generic ingredient in ASENDIN is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Asendin

A generic version of ASENDIN was approved as amoxapine by WATSON LABS on August 28^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ASENDIN?
What are the global sales for ASENDIN?
What is Average Wholesale Price for ASENDIN?

Summary for ASENDIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	117
Patent Applications:	4,294
DailyMed Link:	ASENDIN at DailyMed

Drug patent expirations by year for ASENDIN

US Patents and Regulatory Information for ASENDIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-004	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ASENDIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ASENDIN

See the table below for patents covering ASENDIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Switzerland	517759	Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine	⤷ Sign Up
Netherlands	6803570		⤷ Sign Up
France	1386724	5-nitro-2-furylthioamide	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ASENDIN

Make Better Decisions: Try a trial or see plans & pricing